Blog
RSS FeedPosted by Michael Wonder on 06 May 2022
Patient reported outcome assessment must be inclusive and equitable
5 May 2022 - Patient reported outcomes are increasingly collected in clinical trials and in routine clinical practice, but strategies ...
Posted by Michael Wonder on 08 Mar 2022
Vaccine approval before Phase 3 trial results: a consequence of vaccine access inequity
2 March 2022 - The final Phase 3 clinical data for CanSino Biologics' adenovirus type 5 vector vaccine show that Ad5-nCoV ...
Posted by Michael Wonder on 02 Feb 2022
Equity in cancer drug access in the UK
1 February 2022 - In draft guidance published on 5 January 2022, NICE announced their decision not to recommend the use ...
Posted by Michael Wonder on 08 Dec 2021
Funding Keytruda for melanoma but not for lung cancer is racist, health advocates say
8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...
Posted by Michael Wonder on 11 Nov 2021
Inclusion in health technology assessments: the first step toward equity
10 November 2021 - Many researchers working on health technology assessments are keen to address disparities in health care. ...
Posted by Michael Wonder on 26 Sep 2021
On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19
24 September 2021 - The World Health Organization welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, ...
Posted by Michael Wonder on 19 Aug 2021
Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says
19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...
Posted by Michael Wonder on 04 Jul 2021
ICER to test principle of fair access to fairly priced pharmaceuticals
2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...
Posted by Michael Wonder on 07 Feb 2021
Modifying NICE’s approach to equity weighting
7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...
Posted by Michael Wonder on 30 Jan 2021
Vaccine distribution—equity left behind?
29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...
Posted by Michael Wonder on 15 Dec 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...
Posted by Michael Wonder on 03 Nov 2020
PHARMAC funding resources to focus on medicines access equity
3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...
Posted by Michael Wonder on 21 Oct 2020
Access to the latest and most effective diabetes drugs depends on where you live and what you earn
21 October 2020 - Access to the latest and most effective drugs for Australians with diabetes can depend on where ...
Posted by Michael Wonder on 20 Oct 2020
COVID-19 vaccines: time to talk about the uncertainties
20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...
Posted by Michael Wonder on 07 Oct 2020
Countries pledge nearly US$1 billion to support equitable access to COVID-19 vaccines
6 October 2020 - Gavi, the Vaccine Alliance has welcomed pledges made this week in support of the Gavi COVAX AMC, ...